What is the underlying pathophysiological mechanism responsible for hereditary angioedema?
সমাধান
সঠিক উত্তর: Option A
- Hereditary angioedema (HAE) is primarily caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH).
- This protein normally regulates the complement system, as well as the kallikrein-kinin and coagulation pathways.
- In HAE, the lack of functional C1-INH leads to uncontrolled activation of the complement system and excessive generation of bradykinin, a potent vasodilator that increases vascular permeability, resulting in the characteristic episodes of angioedema.
To elaborate:
- C1 esterase inhibitor is a serine protease inhibitor that controls the activation of the complement system by inhibiting C1r and C1s enzymes.
- When C1-INH is deficient or dysfunctional, there is excessive activation of the classical complement pathway.
- This also causes increased activity of plasma kallikrein, which leads to elevated bradykinin levels.
- Bradykinin causes vasodilation and increased vascular permeability, producing the swelling seen in hereditary angioedema.
The other options are incorrect because:
- Option 2 and 3 involve mast cell activation and histamine release, mechanisms typical of allergic reactions, not hereditary angioedema.
- Option 4 is incorrect because it mentions plasma kallikrein deficiency; in fact, plasma kallikrein activity is increased, not deficient, in HAE.
In summary, the key pathophysiological mechanism is the deficiency of C1 esterase inhibitor leading to unchecked complement activation and increased bradykinin-mediated vascular permeability.
Reference: *Robbins & Cotran Pathologic Basis of Disease, 10th Edition, Volume 1, Chapter 9 (Disorders of the Immune System)*
- This protein normally regulates the complement system, as well as the kallikrein-kinin and coagulation pathways.
- In HAE, the lack of functional C1-INH leads to uncontrolled activation of the complement system and excessive generation of bradykinin, a potent vasodilator that increases vascular permeability, resulting in the characteristic episodes of angioedema.
To elaborate:
- C1 esterase inhibitor is a serine protease inhibitor that controls the activation of the complement system by inhibiting C1r and C1s enzymes.
- When C1-INH is deficient or dysfunctional, there is excessive activation of the classical complement pathway.
- This also causes increased activity of plasma kallikrein, which leads to elevated bradykinin levels.
- Bradykinin causes vasodilation and increased vascular permeability, producing the swelling seen in hereditary angioedema.
The other options are incorrect because:
- Option 2 and 3 involve mast cell activation and histamine release, mechanisms typical of allergic reactions, not hereditary angioedema.
- Option 4 is incorrect because it mentions plasma kallikrein deficiency; in fact, plasma kallikrein activity is increased, not deficient, in HAE.
In summary, the key pathophysiological mechanism is the deficiency of C1 esterase inhibitor leading to unchecked complement activation and increased bradykinin-mediated vascular permeability.
Reference: *Robbins & Cotran Pathologic Basis of Disease, 10th Edition, Volume 1, Chapter 9 (Disorders of the Immune System)*